Brief Report| Volume 44, ISSUE 11, P1420-1421, November 01, 2016

How will the MMR universal mass vaccination change the epidemiologic pattern of mumps? A 2012 Italian serosurvey


      • Evaluation of MMR vaccination on the epidemiological pattern of mumps.
      • A sero-survey was conducted among Apulian blood donors in 2012.
      • 93.4% (95% CI = 92.1-94.5) showed a positive anti-Mumps IgG titre.
      • 10% of people aged 18-26 years (target of vaccination strategy) was susceptible for mumps.
      • Research must be focused on the long time immunogenicity of mumps vaccine.
      To investigate the changes in the epidemiologic pattern of mumps, we carried out a serosurvey among young adults from Apulia, Italy. A convenience sample of 1,764 blood donors were enrolled in 2012: 93.4% (95% confidence interval, 92.1-94.5) showed a positive antimumps immunoglobulin G titre, geometric mean titer was 2.05. Results were consistent with previously published data on the immunogenicity of mumps vaccine but showed a lack of immunity (10% of people aged 18-26 years susceptible for mumps). Future research must be focused on the long-time immunogenicity of the mumps vaccine.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Piccirilli G.
        • Lazzarotto T.
        • Chiereghin A.
        • Serra L.
        • Gabrielli L.
        • Lanari M.
        Spotlight on measles in Italy: why outbreaks of a vaccine-preventable infection continue in the 21st century.
        Expert Rev Anti Infect Ther. 2015; 13: 355-362
        • Ciofi degli Atti M.
        • Salmaso S.
        [The national Plan for the eradication of measles and congenital rubella].
        Epidemiol Prev. 2004; 28: 7-8
        • De Laval F.
        • Haus R.
        • Spiegel A.
        • Simon F.
        Lower long-term immunogenicity of mumps component after MMR vaccine.
        Pediatr Infect Dis J. 2010; 29: 1062-1063
        • Greenland K.
        • Whelan J.
        • Fanoy E.
        • Borgert M.
        • Hulshof K.
        • Yap K.B.
        • et al.
        Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010.
        Vaccine. 2012; 30: 4676-4680
        • Whelan J.
        • van Binnendijk R.
        • Greenland K.
        • Fanoy E.
        • Khargi M.
        • Yap K.
        • et al.
        Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010.
        Euro Surveill. 2010; 15 (pii: 19554)
        • Trevisan A.
        • Morandin M.
        • Frasson C.
        • Paruzzolo P.
        • Davanzo E.
        • Marco L.D.
        • et al.
        Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination.
        Vaccine. 2006; 24: 171-176
        • Cozza V.
        • Martinelli D.
        • Cappelli M.G.
        • Tafuri S.
        • Fortunato F.
        • Prato R.
        Further efforts in the achievement of congenital rubella syndrome/rubella elimination.
        Hum Vaccin Immunother. 2015; 11: 220-224
        • Italian Institute of Statistics (ISTAT). Demography in numbers
        (Available from:) (Accessed January, 2 2016)
        • Abrams S.
        • Beutels P.
        • Hens N.
        Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data.
        Am J Epidemiol. 2014; 179: 1006-1017
        • Anis E.
        • Grotto I.
        • Moerman L.
        • Warshavsky B.
        • Slater P.E.
        • Lev B.
        Mumps outbreak in Israel's highly vaccinated society: are two doses enough?.
        Epidemiol Infect. 2012; 140: 439-446